Page 28 - Stephen Saad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Promit Mukherjee GQEBERHA, South Africa (Reuters) -South Africa s Aspen Pharmacare is aiming to ramp up its COVID-19 vaccine manufacturing capacity to 1.3 billion doses a year by February 2024, up from a current annual output of around 250 million doses, the company s CEO told Reuters on Monday. Aspen is doing the final stages of manufacturing for Johnson & Johnson s COVID-19 vaccine under a so-called fill and finish deal, but CEO Stephen Saad said in an interview that the companies were close to announcing a broader deal for Aspen to produce J&J s COVID-19 shot under licence. We have got an absolute commitment to 700 million doses till February 2023 . within a year after that, we could get (to) 1.3 billion doses, Saad said on the sidelines of the opening of Aspen s anaesthetic manufacturing facility at Gqeberha in eastern South Africa. The company is currently delivering 250 million doses of the final packaged versions of J&J s COVID-19 vaccine on an annualised basis and would reac

South africaUnited statesSouth africanAfrica aspen pharmacareEbrahim patelPromit mukherjeeDavid holmesStephen saadAfrican unionWorld health organisationAspen pharmacareOne africaIndustry ebrahim patel